Flap Vs Flapless Technique for Delayed Implant Placement in the Maxillary Esthetic Zone (NCT07654452) | Clinical Trial Compass
CompletedNot Applicable
Flap Vs Flapless Technique for Delayed Implant Placement in the Maxillary Esthetic Zone
Egypt16 participantsStarted 2025-01-10
Plain-language summary
This randomized comparative clinical trial aims to evaluate the clinical, radiographic, and esthetic outcomes of flap versus flapless techniques for delayed dental implant placement in the maxillary esthetic zone. Sixteen patients requiring implant placement in the maxillary anterior or premolar region will be randomly allocated into two equal groups. Group I will undergo implant placement using the conventional flap technique, while Group II will receive implant placement using the flapless technique. Clinical outcomes including postoperative pain, edema, surgical insertion time, and implant stability will be assessed. Radiographic evaluation will include peri-implant bone quantity, bone quality, and crestal bone loss. Follow-up examinations will be performed immediately after surgery and at 1, 3 and 6 months postoperatively.
Who can participate
Age range
30 Years – 50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients aged from 30 to 50 years old.
* Adults of both genders.
* Patients who are free from any systemic disease (ASA I).
* Patients with teeth loss at upper anterior and premolar regions more than 1-year.
* Presence of sufficient apical and peripheral bone to achieve primary implant stability (minimum 3-5 mm of bone beyond the socket apex and overall socket length ≥ 10 mm).
* Patients with bone quality classified as D3, as assessed by pre-operative CBCT.
Exclusion Criteria:
* Pregnant and lactating women.
* Heavy smoking (\>10 cigarettes/day)
* Patients with bad oral habits such as bruxism.
* Patients with poor oral hygiene.
* Patients with gingival diseases.
* Patients with periodontal diseases (with severe vertical or horizontal bone loss).
* Teeth with periapical or lateral infection or lesions.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Implant Stability Quotient (ISQ)
Timeframe: Immediately after implant placement and 6 months postoperatively.
2
Marginal Crestal Bone Loss
Timeframe: Immediately postoperative, 1 month, 3 months, and 6 months.
3
Relative bone density
Timeframe: Immediately postoperative, 1 month, 3 months, and 6 months.